scispace - formally typeset
E

Eric Verdin

Researcher at Buck Institute for Research on Aging

Publications -  399
Citations -  57682

Eric Verdin is an academic researcher from Buck Institute for Research on Aging. The author has contributed to research in topics: Acetylation & SIRT3. The author has an hindex of 115, co-authored 370 publications receiving 47971 citations. Previous affiliations of Eric Verdin include Institut national de la recherche agronomique & University of California, Berkeley.

Papers
More filters
Journal ArticleDOI

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

David E. Gordon, +128 more
- 30 Apr 2020 - 
TL;DR: A human–SARS-CoV-2 protein interaction map highlights cellular processes that are hijacked by the virus and that can be targeted by existing drugs, including inhibitors of mRNA translation and predicted regulators of the sigma receptors.
Journal ArticleDOI

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase

TL;DR: A human ortholog of Sir2p, sirtuin type 2 (SIRT2), is a predominantly cytoplasmic protein that colocalizes with microtubules and is established as a bona fide tubulin deacetylase.
Journal ArticleDOI

Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor

TL;DR: It is reported that the ketone body d-β-hydroxybutyrate (βOHB) is an endogenous and specific inhibitor of class I histone deacetylases (HDACs), and treatment of mice with βOHB conferred substantial protection against oxidative stress.